摘要
Magnetic nanoparticles(MNPs)based hyperthermia therapy offers a promising cancer treatment owing to its high controllability and safety nature[1].However,several fundamental challenges remain regarding the clinical translation of existing MNPs[2].
作者
林凎
张阳
刘刚
Gan Lin;Yang Zhang;Gang Liu(State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics&Center for Molecular Imaging and Translational Medicine,School of Public Health,Xiamen University,Xiamen 361102,China)
基金
supported by the Major State Basic Research Development Program of China(2017YFA0205201)
the National Natural Science Foundation of China(81925019,81422023,and U1705281)
the Fundamental Research Funds for the Central Universities(20720190088 and 20720200019)
the Medical and Health Key project of Xiamen(3502Z20191106)
the Program for New Century Excellent Talents in University,China(NCET-13-0502)。
